Peifang Jiang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Peifang Jiang has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
Tao Zhu
Department of Critical Care Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province 310020, China
9 shared publicationsLifen Gong
Department of Neurology, Department of Neurobiology and Department of Rehabilitation, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou 310052, China
7 shared publicationsChen Chen
Department of Neurology, Department of Neurobiology and Department of Rehabilitation, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center For Child Health, Hangzhou 310052, China
6 shared publications- Yicheng Xie
Department of Pediatric Endoscopy and Pulmonology, Children's Hospital National Clinical Research Center for Children and Adolescents' Health and Diseases, Zhejiang University School of Medicine Hangzhou Zhejiang China
5 shared publications Yingchao Ying
Department of Neurology, Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, China
5 shared publicationsJunchao Ding
Department of Neurology, The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou, Zhejiang Province 310052, China; Department of Pediatrics, Yiwu Maternal and Child Health Care Hospital, Yiwu, Zhejiang Province 322000, China
4 shared publications
Latest Publications
- Open Access
- 2 September 2026
- Published by Springer Nature in Cell & Bioscience
Hexokinase 2 reduces aberrant neurogenesis by promoting TREM2-mediated microglial phagocytosis in epilepsy mouse model
- 2 September 2026
- Published by Springer Nature in Cell & Bioscience
Open AccessHexokinase 2 reduces aberrant neurogenesis by promoting TREM2-mediated microglial phagocytosis in epilepsy mouse model
- Open Access
- 1 April 2026
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 15 (4) , 143
Global, regional and national burden of epilepsy secondary to four major neonatal disorders: insights from the Global Burden of Disease Study 2021
Background: Neonatal disorders are increasingly recognized as critical contributors to lifelong neurological disability, yet comprehensive global assessments of their impact on secondary epilepsy remain limited. This study aimed to analyze the long-term global burden, regional disparities, and etiological patterns of epilepsy secondary to four major neonatal disorders: preterm birth, sepsis, encephalopathy, and hemolytic disease. Methods: Using data from the Global Burden of Disease Study 2021, we assessed the prevalence, years lived with disability (YLDs), and age-standardized rates of epilepsy attributable to the four major neonatal disorders from 1990 to 2021. Trends were quantified with estimated annual percentage change. Associations with the Socio-demographic Index (SDI) were evaluated using Spearman’s correlation and inequality analysis. Frontier analysis explored efficiency in prevention, and decomposition analysis identified key drivers of YLD changes. Results: In 2021, epilepsy cases from these neonatal disorders reached 22.1 million, accounting for 42.7% of all epilepsy cases globally. The age-standardized prevalence rate (ASPR) increased to 286.0 per 100,000 population. The burden exhibited significant disparities: higher in males at younger ages but shifting to females in older groups, and peaked in childhood. South Asia and the Caribbean had the highest burdens. Neonatal preterm birth was the dominant cause globally, but neonatal encephalopathy due to birth asphyxia and trauma led in East Asia, while neonatal sepsis and other neonatal infections was primary in Eastern Europe. The correlation between disease burden and SDI varied markedly by etiology and metric: ASPR was positively correlated with SDI for preterm birth, sepsis, and encephalopathy, but negatively for hemolytic disease; patterns for age-standardized YLD rate (ASYR) were more heterogeneous. Inequality patterns varied by etiology. Population growth was the primary driver of increasing YLDs. Conclusions: Epilepsy secondary to major neonatal disorders constitutes a substantial and growing global health burden, marked by significant regional, etiological, and socioeconomic disparities. Targeted strategies are urgently needed, focusing on high-burden regions, addressing shifting epidemiological patterns, and expanding rehabilitation services to mitigate disability and reduce inequalities.
- 1 April 2026
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 15 (4) , 143
Open AccessGlobal, regional and national burden of epilepsy secondary to four major neonatal disorders: insights from the Global Burden of Disease Study 2021
Background: Neonatal disorders are increasingly recognized as critical contributors to lifelong neurological disability, yet comprehensive global assessments of their impact on secondary epilepsy remain limited. This study aimed to analyze the long-term global burden, regional disparities, and etiological patterns of epilepsy secondary to four major neonatal disorders: preterm birth, sepsis, encephalopathy, and hemolytic disease. Methods: Using data from the Global Burden of Disease Study 2021, we assessed the prevalence, years lived with disability (YLDs), and age-standardized rates of epilepsy attributable to the four major neonatal disorders from 1990 to 2021. Trends were quantified with estimated annual percentage change. Associations with the Socio-demographic Index (SDI) were evaluated using Spearman’s correlation and inequality analysis. Frontier analysis explored efficiency in prevention, and decomposition analysis identified key drivers of YLD changes. Results: In 2021, epilepsy cases from these neonatal disorders reached 22.1 million, accounting for 42.7% of all epilepsy cases globally. The age-standardized prevalence rate (ASPR) increased to 286.0 per 100,000 population. The burden exhibited significant disparities: higher in males at younger ages but shifting to females in older groups, and peaked in childhood. South Asia and the Caribbean had the highest burdens. Neonatal preterm birth was the dominant cause globally, but neonatal encephalopathy due to birth asphyxia and trauma led in East Asia, while neonatal sepsis and other neonatal infections was primary in Eastern Europe. The correlation between disease burden and SDI varied markedly by etiology and metric: ASPR was positively correlated with SDI for preterm birth, sepsis, and encephalopathy, but negatively for hemolytic disease; patterns for age-standardized YLD rate (ASYR) were more heterogeneous. Inequality patterns varied by etiology. Population growth was the primary driver of increasing YLDs. Conclusions: Epilepsy secondary to major neonatal disorders constitutes a substantial and growing global health burden, marked by significant regional, etiological, and socioeconomic disparities. Targeted strategies are urgently needed, focusing on high-burden regions, addressing shifting epidemiological patterns, and expanding rehabilitation services to mitigate disability and reduce inequalities.
- 26 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112744
3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy
- 26 July 2024
- Published by Elsevier in International Immunopharmacology
- Vol. 139, 112744
3-Methyladenine attenuates neuroinflammation and improves cognitive function in sepsis-associated encephalopathy by inhibiting autophagy
- Open Access
- 28 August 2023
- Published by Elsevier in Neurobiology of Disease
- Vol. 186, 106273
Trpm2 deficiency in microglia attenuates neuroinflammation during epileptogenesis by upregulating autophagy via the AMPK/mTOR pathway
- 28 August 2023
- Published by Elsevier in Neurobiology of Disease
- Vol. 186, 106273
Open AccessTrpm2 deficiency in microglia attenuates neuroinflammation during epileptogenesis by upregulating autophagy via the AMPK/mTOR pathway
- 8 May 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 145, 135-147
A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B With Wilson Disease in China
- 8 May 2023
- Published by Elsevier in Pediatric Neurology
- Vol. 145, 135-147
A Systematic Review and Meta-Analysis of the R778L Mutation in ATP7B With Wilson Disease in China
- 1 November 2022
- Published by Edizioni Minerva Medica in Minerva Pediatrics
- Vol. 74 (5) , 615-617
Effect of anesthesia on neonatal immunity
Article: Effect of anesthesia on neonatal immunity - Minerva Pediatrics 2022 May18 - Minerva Medica - Journals
- 1 November 2022
- Published by Edizioni Minerva Medica in Minerva Pediatrics
- Vol. 74 (5) , 615-617
Effect of anesthesia on neonatal immunity
Article: Effect of anesthesia on neonatal immunity - Minerva Pediatrics 2022 May18 - Minerva Medica - Journals
- 2 September 2022
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (11) , 6918-6933
Genetic Knockout of TRPM2 Increases Neuronal Excitability of Hippocampal Neurons by Inhibiting Kv7 Channel in Epilepsy
Epilepsy is a chronic brain disease that makes serious cognitive and motor retardation. Ion channels affect the occurrence of epilepsy in various ways, but the mechanisms have not yet been fully elucidated. Transient receptor potential melastain2 (TRPM2) ion channel is a non-selective cationic channel that can permeate Ca2+ and critical for epilepsy. Here, TRPM2 gene knockout mice were used to generate a chronic kindling epilepsy model by PTZ administration in mice. We found that TRPM2 knockout mice were more susceptible to epilepsy than WT mice. Furthermore, the neuronal excitability in the hippocampal CA1 region of TRPM2 knockout mice was significantly increased. Compared with WT group, there were no significant differences in the input resistance and after hyperpolarization of CA1 neurons in TRPM2 knockout mice. Firing adaptation rate of hippocampal CA1 pyramidal neurons of TRPM2 knockout mice was lower than that of WT mice. We also found that activation of Kv7 channel by retigabine reduced the firing frequency of action potential in the hippocampal pyramidal neurons of TRPM2 knockout mice. However, inhibiting Kv7 channel increased the firing frequency of action potential in hippocampal pyramidal neurons of WT mice. The data suggest that activation of Kv7 channel can effectively reduce epileptic seizures in TRPM2 knockout mice. We conclude that genetic knockout of TRPM2 in hippocampal CA1 pyramidal neurons may increase neuronal excitability by inhibiting Kv7 channel, affecting the susceptibility to epilepsy. These findings may provide a potential therapeutic target for epilepsy.
- 2 September 2022
- Published by Springer Nature in Molecular Neurobiology
- Vol. 59 (11) , 6918-6933
Genetic Knockout of TRPM2 Increases Neuronal Excitability of Hippocampal Neurons by Inhibiting Kv7 Channel in Epilepsy
Epilepsy is a chronic brain disease that makes serious cognitive and motor retardation. Ion channels affect the occurrence of epilepsy in various ways, but the mechanisms have not yet been fully elucidated. Transient receptor potential melastain2 (TRPM2) ion channel is a non-selective cationic channel that can permeate Ca2+ and critical for epilepsy. Here, TRPM2 gene knockout mice were used to generate a chronic kindling epilepsy model by PTZ administration in mice. We found that TRPM2 knockout mice were more susceptible to epilepsy than WT mice. Furthermore, the neuronal excitability in the hippocampal CA1 region of TRPM2 knockout mice was significantly increased. Compared with WT group, there were no significant differences in the input resistance and after hyperpolarization of CA1 neurons in TRPM2 knockout mice. Firing adaptation rate of hippocampal CA1 pyramidal neurons of TRPM2 knockout mice was lower than that of WT mice. We also found that activation of Kv7 channel by retigabine reduced the firing frequency of action potential in the hippocampal pyramidal neurons of TRPM2 knockout mice. However, inhibiting Kv7 channel increased the firing frequency of action potential in hippocampal pyramidal neurons of WT mice. The data suggest that activation of Kv7 channel can effectively reduce epileptic seizures in TRPM2 knockout mice. We conclude that genetic knockout of TRPM2 in hippocampal CA1 pyramidal neurons may increase neuronal excitability by inhibiting Kv7 channel, affecting the susceptibility to epilepsy. These findings may provide a potential therapeutic target for epilepsy.
- Open Access
- 22 July 2022
- Published by Elsevier in Neurobiology of Disease
- Vol. 172, 105823
Miconazole exerts disease-modifying effects during epilepsy by suppressing neuroinflammation via NF-κB pathway and iNOS production
- 22 July 2022
- Published by Elsevier in Neurobiology of Disease
- Vol. 172, 105823
Open AccessMiconazole exerts disease-modifying effects during epilepsy by suppressing neuroinflammation via NF-κB pathway and iNOS production
- Open Access
- 11 April 2022
- Published by Springer Nature in Research Square
TRPM2 regulates the excitability of hippocampal neurons through Kv7 channel in epilepsy
Transient receptor potential Melastain2 (TRPM2) ion channel is a non-selective cationic channel that can permeate Ca2+ and is highly expressed in the brain, especially in the cerebral cortex, hippocampus, and striatum, which are critical for cognitive function. Current research evidence indicates that TRPM2 is closely associated with various neurological diseases such as epilepsy. In this study, TRPM2 gene knockout mice were used to study the effect of TRPM2 on the susceptibility to epilepsy in mice and the specific mechanism of the impact of TRPM2 on epilepsy by affecting neuronal excitability. In PTZ chronic kindling epilepsy model, we have found that TRPM2 knockout mice were more susceptible to epilepsy than WT mice. Furthermore, the neuronal excitability in the hippocampal CA1 region of TRPM2 knockout mice is significantly increased. Compared with WT group, there were no significant differences in the input resistance and afterhyperpolarization of CA1 neurons in TRPM2 knockout mice. Firing adaptation rate of hippocampal CA1 pyramidal neurons of TRPM2 knockout mice is lower than that of WT mice. We found that activation of Kv7 channel by retigabine reduced the firing frequency of action potential in the hippocampal pyramidal neurons of TRPM2 knockout mice. However, inhibiting Kv7 channel increased the firing frequency of action potential in hippocampal pyramidal neurons of WT mice. In animal models, we confirmed that activation of Kv7 channel can effectively reduce epileptic seizures in TRPM2 knockout mice. These results suggest that hippocampal CA1 pyramidal neurons in TRPM2 knockout mice may increase neuronal excitability by inhibiting the Kv7 channel, thus affecting the susceptibility to epilepsy. This study carefully explores the reasons why TRPM2 knockout is more susceptible to epilepsy, which is helpful to understand the occurrence and development of epilepsy, and provides new ideas for the treatment technology and methods of epilepsy.
- 11 April 2022
- Published by Springer Nature in Research Square
Open AccessTRPM2 regulates the excitability of hippocampal neurons through Kv7 channel in epilepsy
Transient receptor potential Melastain2 (TRPM2) ion channel is a non-selective cationic channel that can permeate Ca2+ and is highly expressed in the brain, especially in the cerebral cortex, hippocampus, and striatum, which are critical for cognitive function. Current research evidence indicates that TRPM2 is closely associated with various neurological diseases such as epilepsy. In this study, TRPM2 gene knockout mice were used to study the effect of TRPM2 on the susceptibility to epilepsy in mice and the specific mechanism of the impact of TRPM2 on epilepsy by affecting neuronal excitability. In PTZ chronic kindling epilepsy model, we have found that TRPM2 knockout mice were more susceptible to epilepsy than WT mice. Furthermore, the neuronal excitability in the hippocampal CA1 region of TRPM2 knockout mice is significantly increased. Compared with WT group, there were no significant differences in the input resistance and afterhyperpolarization of CA1 neurons in TRPM2 knockout mice. Firing adaptation rate of hippocampal CA1 pyramidal neurons of TRPM2 knockout mice is lower than that of WT mice. We found that activation of Kv7 channel by retigabine reduced the firing frequency of action potential in the hippocampal pyramidal neurons of TRPM2 knockout mice. However, inhibiting Kv7 channel increased the firing frequency of action potential in hippocampal pyramidal neurons of WT mice. In animal models, we confirmed that activation of Kv7 channel can effectively reduce epileptic seizures in TRPM2 knockout mice. These results suggest that hippocampal CA1 pyramidal neurons in TRPM2 knockout mice may increase neuronal excitability by inhibiting the Kv7 channel, thus affecting the susceptibility to epilepsy. This study carefully explores the reasons why TRPM2 knockout is more susceptible to epilepsy, which is helpful to understand the occurrence and development of epilepsy, and provides new ideas for the treatment technology and methods of epilepsy.